{"company":{"slug":"trigemx-bio","name":"TriGemX Bio","stage":"unknown","industry":"bio-health","subcategory":null,"sector":"Biotechnology, Health Care, Medical, Pharmaceutical","description":"TriGemX Bio uses the science of gut-brain biology to create medicines that transform human health.","crypto":false,"first_seen_at":"2026-10-03T19:54:46.076Z","hq_city":"New York","hq_country":"United States","founded_year":null,"website":"https://trigemxbio.com","x_handle":null,"followers":null,"logo":"https://recentfunding.com/logo/u/aHR0cHM6Ly9pbWFnZXMuY3J1bmNoYmFzZS5jb20vaW1hZ2UvdXBsb2FkL2FjZmM2Y2RhYzBmNDQyNTdiZmNmNWQ4MmIzMGZhM2Fk","amount_usd":"94000000.00","announced_at":"2026-10-01T00:00:00.000Z","raise_source_url":"https://www.businesswire.com/news/home/20260930522593/en/TriGemX-Bio-Announces-%2494M-Financing-and-Initiation-of-Phase-3-Trials-for-Elismetrep-A-Potential-First-in-Class-Treatment-for-Migraine","raise_publisher":"businesswire.com","raise_provider":"crunchbase","sources":[],"investors":["Bill & Melinda Gates Foundation","Bill Gates","Casdin Capital","Euclidean Capital","Polaris Partners","Tao Capital Partners","TCG Crossover","The Column Group","Viking Global Investors"],"flagged":false,"flagged_at":null,"source_links":{},"x_created_at":null,"domain_created_at":null,"smart_follows":null,"days_early":null,"new_follows_7d":null,"trending_rank":null,"team_size":null,"team_source_url":null,"categories":["health-bio"]},"rounds":[{"stage":"unknown","amount_usd":"94000000.00","valuation_usd":null,"announced_at":"2026-10-01T00:00:00.000Z","source_url":"https://www.businesswire.com/news/home/20260930522593/en/TriGemX-Bio-Announces-%2494M-Financing-and-Initiation-of-Phase-3-Trials-for-Elismetrep-A-Potential-First-in-Class-Treatment-for-Migraine","source_publisher":"businesswire.com","source_provider":"crunchbase"}],"founders":[{"name":"Alex Rives","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Founder","source_url":null,"other_companies":[]},{"name":"Charles Zuker","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Founder","source_url":null,"other_companies":[]},{"name":"Richard Axel","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Founder","source_url":null,"other_companies":[]},{"name":"Thomas Maniatis","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Founder","source_url":null,"other_companies":[]},{"name":"Nancy Thornberry","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Member, Board of Directors and Chair, R&D","source_url":null,"other_companies":[]},{"name":"Anita Kawatra","x_handle":null,"linkedin_url":null,"avatar":null,"role":"EVP, Corporate Affairs","source_url":null,"other_companies":[]},{"name":"Brett Lauring","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Chief Medical Officer","source_url":null,"other_companies":[]},{"name":"Cariad Chester","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Board member","source_url":null,"other_companies":[]},{"name":"Fernando Salles","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Chief Business Offcier","source_url":null,"other_companies":[]},{"name":"Jay Galeota","x_handle":null,"linkedin_url":null,"avatar":null,"role":"President & Chief Executive Officer","source_url":null,"other_companies":[]},{"name":"Jeff Goater","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Board member","source_url":null,"other_companies":[]},{"name":"Josh Wolfe","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Board member","source_url":null,"other_companies":[]},{"name":"Patrick Flanigan III","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Chief Financial Officer","source_url":null,"other_companies":[]},{"name":"Peter M. Hecht","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Board member","source_url":null,"other_companies":[]},{"name":"Shirly Pinto","x_handle":null,"linkedin_url":null,"avatar":null,"role":"Chief Scientific Officer","source_url":null,"other_companies":[]}]}